The model concluded that the decreased resources, including shorter hospital stays and lower hemostat use, could potentially save medium volume U.S. hospitals $2,445 per spinal procedure. 2 The ...

Hemopatch Sealing Hemostat with room temperature storage now available in Europe New product evolution enables direct accessibility in the operating room Innovation is a direct result of collaborative ...

Ax-Surgi Surgical Hemostat, a chitosan-based hemostat for controlling severe surgical bleeding, developed by Axio Biosolutions, has received the US Food and Drug Administration (FDA) 510(k) clearance.

Z-Medica Corporation, a medical device company developing innovative hemostatic agents, today announced the availability of the QuikClot® Interventional™ hemostatic bandage, on display at booth #1338 ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of the Disposable Curved Applicator, which ...

NEW YORK, June 12, 2024 /PRNewswire/ --The global hemostats and tissue sealants market size is estimated to grow by USD 3.355 billion from 2024-2028, according to Technavio. The market is estimated to ...

COLLEGE PARK, Md., Feb. 19, 2018 /PRNewswire/ -- gel-e Inc., announces two new grants that support the development of internal use hemostats. gel-e has been awarded a $1.4M grant from the Department ...

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature storage at a symposium in ...

Innovation is a direct result of collaborative efforts with surgeons, helping to ensure that customer needs are met and promoting enhanced patient care "For over a decade, Hemopatch Sealing Hemostat ...